Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the appointment of Karen Quinn Ph.D as Vice President Corticotropin Regulatory...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported record financial results for the three and nine months ended September 30, 2016, and...
ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced that it has received approval from the U.S. Food and Drug Administration ("FDA") of...
ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the commercial launch of authorized generic Rowasa® (mesalamine) rectal suspension...
ANI Pharmaceuticals, Inc. ("ANI") (Nasdaq: ANIP) today announced the commercial launch of 1% and 2.5% hydrocortisone cream for rectal use. The...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that its collaboration partner Dexcel Pharma Technologies Ltd. ("Dexcel") has...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and twelve months ended December 31, 2015, and...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has completed the acquisition of the NDAs for purified corticotropin gel and ...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the commercial launch of Nimodipine 30mg Capsules, a product developed by...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced the launch of Propafenone Hydrochloride 150mg, 225mg and 300mg oral tablets,...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today announced that it has acquired the approved abbreviated new drug application ("ANDA") for...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its fourth quarter and full year 2014 financial results on ...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the "Company") today announced that it has closed an underwritten public offering of its 3.00% Convertible...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) (the "Company") today announced that it is offering $100,000,000 aggregate principal amount of Convertible...
ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ANIP) today reported financial results for the three and nine months ended September 30, 2014 and...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its third quarter and year-to-date 2014 financial results...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its second quarter and year-to-date 2014 financial results ...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that the Company plans to release its first quarter 2014 financial results on Monday, May 5, ...
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced today that its President and Chief Executive Officer, Arthur S. Przybyl, is scheduled to present...
ANI Pharmaceuticals, Inc. (the "Company") (NASDAQ: ANIP) today announced that it intends to offer its common stock in a registered public offering...
ANI Pharmaceuticals (NASDAQ: ANIP) today announced that it has signed a binding letter of intent for the development of an oral soft gel prescription ...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.